Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias

Rahul S. Vedula, Hannah Q. Karp, Jeremy Koob, Felicia Lim, Jacqueline S. Garcia, Eric S. Winer, Marlise R. Luskin, Gabriel Ghiaur, Annette S. Kim, Lan W. Beppu, Olga Sala-Torra, Jerald Radich, Jonathan Gootenberg, Omar Abudayyeh, Feng Zhang, R. Coleman Lindsley

Blood (2024) 144 (12): 1290–1299.

https://doi.org/10.1182/blood.2023022908

Published: 2024

Includes: Supplemental data

Journal Articles

Rapid Clinical Mutation Screening for AML Using the Genexus Platform

Shahanawaz Jiwani, Jerald P. Radich, Maria Saeed, Lauri Aicher, Ting-Chia Chang, Srikrishna Narava, Zaneta Holman, Lan Beppu, Olga Sala-Torra, Marvin Majano, Erin Taylor, Laura Yee, Jessica Li, Lisa McShane, Pooja CS Sanduria, Paul Mickey M. Williams, Cecilia C.S. Yeung

Blood (2023) 142 (Supplement 1): 2288.

https://doi.org/10.1182/blood-2023-188270

Published: 2023

Journal Articles

Multiomic Single-Cell Sequencing May Distinguish BCR-ABL-Mutated Acute Myeloid Leukemia (AML) from Blast Crisis Chronic Myelogenous Leukemia (BC-CML)

Vanessa E. Kennedy, Cheryl A C Peretz, Andrew Koh, Elaine Tran, Dalia Dhingra, Saurabh Gulati, Adam Sciambi, Olga Sala-Torra, Lan Beppu, Aaron C. Logan, Alexander Perl, Wendy Stock, Geoffrey L Uy, Ann-Kathrin Eisfeld, Jerald P. Radich, Catherine C. Smith

Blood (2023) 142 (Supplement 1): 4334.

https://doi.org/10.1182/blood-2023-182454

Published: 2023

Journal Articles

High-Resolution Proximity-Guided Cytogenomics Improves Patient Stratification and Uncovers New Variants in Acute Myeloid Leukemia

Stephen Eacker, Maika Malig, Kyle Langford, Alexander Muratov, Mary Wood, Olga Sala-Torra, Shawn T Sullivan, Ivan Liachko, Cecilia C.S. Yeung, Jerald P. Radich

Blood (2023) 142 (Supplement 1): 5980.

https://doi.org/10.1182/blood-2023-190195

Published: 2023

Journal Articles

Minimally Invasive Blood Sampling for BCR::ABL1 transcript Monitoring

Vivian G. Oehler, Olga Sala-Torra, Qian Vicky Wu, Lan Beppu, Emily Welch, Erwin Berthier, Jerald P. Radich

Blood (2022) 140 (Supplement 1): 3883–3884.

https://doi.org/10.1182/blood-2022-167799

Published: 2022

Journal Articles

Reduced-Intensity Therapy with Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Yields Durable Remissions in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Final Results of a Phase II Trial

Ryan D. Cassaday, Kelsey-Leigh A. Garcia, Olga Sala-Torra, Philip A. Stevenson, Christen H. Martino, Yajuan J. Liu, Min Fang, Mary-Elizabeth M. Percival, Anna B. Halpern, Pamela S. Becker, Vivian G. Oehler, Andrei R Shustov, Jason P. Cooper, Johnnie J. Orozco, Paul C. Hendrie, Roland B. Walter, Jerry P. Radich, Lorinda A. Soma, Elihu H. Estey

Blood (2021) 138 (Supplement 1): 4397.

https://doi.org/10.1182/blood-2021-145648

Published: 2021

Journal Articles

Myeloid/Lymphoid Neoplasm with Eosinophilia and a Novel RUFY1-Pdgfrb Rearrangement

Karly Williams Silva, Carrie L. Cummings, Nahid Rashid, Olga Sala-Torra, Xueyan Chen, Yajuan J. Liu, Vivian G. Oehler

Blood (2021) 138 (Supplement 1): 4639.

https://doi.org/10.1182/blood-2021-151703

Published: 2021

Journal Articles

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Is Active and Well-Tolerated in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Initial Results of a Phase II Trial

Ryan D. Cassaday, MD, Lorinda A. Soma, MD, Olga Sala-Torra, MD, Philip A. Stevenson, MS, Mary-Elizabeth M. Percival, MD, Vivian G. Oehler, MD, Andrei R. Shustov, MD, Pamela S. Becker, MD, Anna B. Halpern, MD, Kelsey-Leigh Garcia, Christen N. Heye, ARNP, Jerald P. Radich, MD, Elihu H. Estey, MD

Blood (2018) 132 (Supplement 1): 1419.

https://doi.org/10.1182/blood-2018-99-110661

Published: 2018

Journal Articles

Characterization of the Genomic Landscape of BCR-ABL1 Kinase-Independent Mechanisms of Resistance to ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Blood (2016) 128 (22): 1119.

https://doi.org/10.1182/blood.V128.22.1119.1119

Published: 2016

Journal Articles

Paper or plastic? BCR-ABL1 quantitation and mutation detection from dried blood spots

Olga Sala Torra, Lan Beppu, Jordan L. Smith, Linda Welden, Jasmina Georgievski, Karisma Gupta, Rashmi Kumar, Cecilia C. S. Yeung, Amy Paguirigan, Ted A. Gooley, Susan Branford, Jerald P. Radich

Blood (2016) 127 (22): 2773–2774.

https://doi.org/10.1182/blood-2015-12-689059

Published: 2016

Includes: Supplemental data

Journal Articles

Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333

Olga Sala Torra, MD, Megan Othus, PhD, David W Williamson, PhD, Brent L. Wood, MD PhD, Ilan Kirsch, MD, Harlan Robins, PhD, Margaret O'Donnell, Stephen J. Forman, Frederick R. Appelbaum, MD, Jerald P Radich, MD

Blood (2014) 124 (21): 2399.

https://doi.org/10.1182/blood.V124.21.2399.2399

Published: 2014

Journal Articles

Paper or Plastic: RT-PCR of BCR-ABL from Blood Spots Stored and Shipped on Paper

Olga Sala Torra, MD, Lan Beppu, Susan Branford, PhD, Linda Fletcher, BS, Gooley Ted, PhD, Amy L Paguirigan, PhD, Jordan Smith, Jerald P Radich, MD

Blood (2014) 124 (21): 4566.

https://doi.org/10.1182/blood.V124.21.4566.4566

Published: 2014

Journal Articles

Analysis of CRLF2/JAK Expression and Mutation Status In Adult ALL Patients

Olga Sala Torra, Holly Gundacker, Galina Pogosov, Era Pogosova-Agadjanyan, Stephen J Forman, Margaret O'Donnell, M.D., F.R.C.P.C., Frederick R. Appelbaum, MD, Cheryl L. Willman, MD, Jerald P. Radich, MD

Blood (2010) 116 (21): 758.

https://doi.org/10.1182/blood.V116.21.758.758

Published: 2010

Journal Articles

CD52 Expression In Leukemic Stem/Progenitor Cells

Vivian G. Oehler, MD, Roland B. Walter, MD, PhD, Carrie Cummings, Olga Sala-Torra, MD, Derek L. Stirewalt, MD, Min Fang, MD, PhD, Jerald P. Radich, MD, Brent Wood, MD, PhD

Blood (2010) 116 (21): 2743.

https://doi.org/10.1182/blood.V116.21.2743.2743

Published: 2010

Journal Articles

CAL-101, An Oral p110δ Selective Phosphatidylinositol-3-Kinase (PI3K) Inhibitor for the Treatment of B Cell Malignancies Inhibits PI3K Signaling, Cellular Viability and Protective Signals of the Microenvironment.

Brian J Lannutti, Sarah A Meadows, Adam Kashishian, Bart Steiner, Galina Pogosov, Olga Sala-Torra, Amy J Johnson, John C. Byrd, Jerald Radich, Neill A. Giese

Blood (2009) 114 (22): 286.

https://doi.org/10.1182/blood.V114.22.286.286

Published: 2009

Journal Articles

Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.

Anjali Advani, MD, Holly Gundacker, MS, Olga Sala-Torra, MD, Jerald Radich, MD, Raymond Lai, MD, PhD, Marilyn L. Slovak, PhD, Jeffrey E Lancet, MD, Steve Coutre, MD, Robert K Stuart, MD, Martha P. Mims, MD, PhD, Patrick Stiff, MD, Frederick R. Appelbaum, MD

Blood (2009) 114 (22): 3094.

https://doi.org/10.1182/blood.V114.22.3094.3094

Published: 2009

Journal Articles

DDX3Y encodes a class I MHC–restricted H-Y antigen that is expressed in leukemic stem cells

Kellie V. Rosinski, Nobuharu Fujii, Jeffrey K. Mito, Kevin K. W. Koo, Suzanne M. Xuereb, Olga Sala-Torra, James S. Gibbs, Jerald P. Radich, Yoshiki Akatsuka, Benoît J. Van den Eynde, Stanley R. Riddell, Edus H. Warren

Blood (2008) 111 (9): 4817–4826.

https://doi.org/10.1182/blood-2007-06-096313

Published: 2008

Journal Articles

Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia

Olga Sala-Torra, Holly M. Gundacker, Derek L. Stirewalt, Paula A. Ladne, Era L. Pogosova-Agadjanyan, Marilyn L. Slovak, Cheryl L. Willman, Shelly Heimfeld, David H. Boldt, Jerald P. Radich

Blood (2006) 109 (7): 3080–3083.

https://doi.org/10.1182/blood-2006-06-031096

Published: 2006

Journal Articles

Serious Acute or Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplantation: A Comparison of Myeloablative and Non-Myeloablative Conditioning Regimens.

Olga Sala-Torra, MD, Paul J. Martin, MD, Barry Storer, PhD, Mohamed Sorror, MD, Rainer F. Storb, MD, Brenda M. Sandmaier, MD, Mary E.D. Flowers, MD

Blood (2006) 108 (11): 755.

https://doi.org/10.1182/blood.V108.11.755.755

Published: 2006

Journal Articles

CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia.

Olga Sala-Torra, MD, Holly M. Gundacker, Derek L. Stirewalt, MD, Paula A. Ladne, Era L. Pogosova-Agadjanyan, Marilyn L. Slovak, PhD, Cheryl L. Willman, MD, Shelly Heimfeld, PhD, David H. Boldt, MD, Jerald P. Radich, MD

Blood (2005) 106 (11): 336.

https://doi.org/10.1182/blood.V106.11.336.336

Published: 2005

NARROW

CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias

Rapid Clinical Mutation Screening for AML Using the Genexus Platform

Multiomic Single-Cell Sequencing May Distinguish BCR-ABL-Mutated Acute Myeloid Leukemia (AML) from Blast Crisis Chronic Myelogenous Leukemia (BC-CML)

High-Resolution Proximity-Guided Cytogenomics Improves Patient Stratification and Uncovers New Variants in Acute Myeloid Leukemia

Minimally Invasive Blood Sampling for BCR::ABL1 transcript Monitoring

Reduced-Intensity Therapy with Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Yields Durable Remissions in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Final Results of a Phase II Trial

Myeloid/Lymphoid Neoplasm with Eosinophilia and a Novel RUFY1-Pdgfrb Rearrangement

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Is Active and Well-Tolerated in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Initial Results of a Phase II Trial

Characterization of the Genomic Landscape of BCR-ABL1 Kinase-Independent Mechanisms of Resistance to ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Paper or plastic? BCR-ABL1 quantitation and mutation detection from dried blood spots

Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333

Paper or Plastic: RT-PCR of BCR-ABL from Blood Spots Stored and Shipped on Paper

Analysis of CRLF2/JAK Expression and Mutation Status In Adult ALL Patients

CD52 Expression In Leukemic Stem/Progenitor Cells

CAL-101, An Oral p110δ Selective Phosphatidylinositol-3-Kinase (PI3K) Inhibitor for the Treatment of B Cell Malignancies Inhibits PI3K Signaling, Cellular Viability and Protective Signals of the Microenvironment.

Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.

DDX3Y encodes a class I MHC–restricted H-Y antigen that is expressed in leukemic stem cells

Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia

Serious Acute or Chronic Graft-Versus-Host Disease after Hematopoietic Cell Transplantation: A Comparison of Myeloablative and Non-Myeloablative Conditioning Regimens.

CTGF (CCN2) Predicts OS and DFS in Adult Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only